Unforeseen changes in seasonality of pediatric respiratory illnesses during the first COVID-19 pandemic year.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
06 2022
Historique:
revised: 01 03 2022
received: 17 11 2021
accepted: 10 03 2022
pubmed: 22 3 2022
medline: 21 5 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

To investigate whether the three nationwide coronavirus disease 2019 (COVID-19) lockdowns imposed in Israel during the full first pandemic year altered the traditional seasonality of pediatric respiratory healthcare utilization. Month by month pediatric emergency department (ED) visits and hospitalizations for respiratory diagnoses during the first full COVID-19 year were compared to those recorded for the six consecutive years preceding the pandemic. Data were collected from the patients' electronic files by utilizing a data extraction platform (MDClone A significant decline of 40% in respiratory ED visits and 54%-73% in respiratory hospitalizations during the first COVID-19 year compared with the pre-COVID-19 years were observed (p < 0.001 and p < 0.001, respectively). The rate of respiratory ED visits out of the total monthly visits, mostly for asthma, peaked during June 2020, compared with proceeding years (109 [5.9%] versus 88 [3.9%] visits; p < 0.001). This peak occurred 2 weeks after the lifting of the first lockdown, resembling the "back-to-school asthma" phenomenon of September. This study demonstrates important changes in the seasonality of pediatric respiratory illnesses during the first COVID-19 year, including a new "back-from-lockdown" asthma peak. These dramatic changes along with the recent resurgence of respiratory diseases may indicate the beginnings of altered seasonality in pediatric pulmonary pathologies as collateral damage of the pandemic.

Identifiants

pubmed: 35307986
doi: 10.1002/ppul.25896
pmc: PMC9088630
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1425-1431

Informations de copyright

© 2022 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.

Références

Pediatr Pulmonol. 2021 Jul;56(7):1951-1956
pubmed: 33848402
Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
Arch Dis Child. 1989 Jan;64(1):103-7
pubmed: 2923458
J Asthma. 2009 Sep;46(7):652-5
pubmed: 19728199
Arch Dis Child. 2020 Aug;105(8):809-810
pubmed: 32444452
Pediatr Pulmonol. 2022 Jun;57(6):1425-1431
pubmed: 35307986
Front Pediatr. 2017 May 10;5:103
pubmed: 28540285
Pediatrics. 2014 Apr;133(4):e923-32
pubmed: 24616356
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
J Asthma Allergy. 2021 Feb 03;14:101-108
pubmed: 33568921
J Allergy Clin Immunol Pract. 2020 Jul - Aug;8(7):2384-2385
pubmed: 32371047
J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3378-3387.e11
pubmed: 32827728
Disaster Med Public Health Prep. 2022 Feb;16(1):36-39
pubmed: 32782063
Thorax. 2006 Aug;61(8):722-8
pubmed: 16877691
J Allergy Clin Immunol. 2007 Sep;120(3):526-9
pubmed: 17658590
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2774-2776.e1
pubmed: 32522565
Sci Total Environ. 2020 Jul 15;726:138540
pubmed: 32302810
Nature. 2020 Dec;588(7838):388-390
pubmed: 33324005
Lancet. 2000 Sep 16;356(9234):982-7
pubmed: 11041399
Pediatr Pulmonol. 2021 Jun;56(6):1401-1408
pubmed: 33729709
Clin Rev Allergy Immunol. 2013 Dec;45(3):331-79
pubmed: 23575961
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427
pubmed: 32773660
JAMIA Open. 2020 Dec 14;3(4):557-566
pubmed: 33623891
J Epidemiol Community Health. 2019 Sep;73(9):825-831
pubmed: 31262728
BMC Pediatr. 2020 Sep 7;20(1):427
pubmed: 32894080
Allergy Asthma Proc. 2016 Nov;37(6):475-481
pubmed: 27931303
JAMA Netw Open. 2021 Feb 1;4(2):e2037227
pubmed: 33576819
JAMA Intern Med. 2020 Oct 1;180(10):1328-1333
pubmed: 32744612
Lancet Respir Med. 2020 Nov;8(11):1070-1071
pubmed: 32593314
Thorax. 2004 Dec;59(12):1046-51
pubmed: 15563703
Pediatr Infect Dis J. 2003 Oct;22(10):857-62
pubmed: 14551484

Auteurs

Moria Be'er (M)

Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Israel Amirav (I)

Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michal Cahal (M)

Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Mika Rochman (M)

Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yotam Lior (Y)

Division of Anesthesia, Intensive Care, and Pain Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ayelet Rimon (A)

Department of Pediatric Emergency, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Roni G Lavy (RG)

Department of Pediatric, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moran Lavie (M)

Pediatric Pulmonology Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH